Patents by Inventor Ivie AIFUWA

Ivie AIFUWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220392613
    Abstract: Provided are methods for classifying cells, such as T cells, using machine learning methods. The methods can be used to classify different subsets or types of cells in a mixed population of cells.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 8, 2022
    Applicant: Juno Therapeutics, Inc.
    Inventors: Ivie AIFUWA, Jon Charles GUNTHER, Keith RAWSON, Vanessa HASLE, David REISS
  • Publication number: 20220228101
    Abstract: An automated method of T cell scale down processing. The method including: activating T cells by automatically contacting the T cells with one or more activation reagents; transducing the T cells by automatically contacting the T cells with a recombinant viral vector; automatically inoculating T cells; automatically expanding the T cells; optionally, automatically debeading the T cells; and automatically harvesting the T cells. A system for an automated method of T cell scale down processing.
    Type: Application
    Filed: June 5, 2020
    Publication date: July 21, 2022
    Applicant: JUNO THERAPEUTICS, INC.
    Inventors: Ivie AIFUWA, Pascal BEAUCHESNE, Kien KHUU-DUONG, Kohana LEUBA
  • Publication number: 20210207080
    Abstract: Provided herein is a serum-free media for culturing, such as cultivating, preparing and/or producing cells, such as immune cells, such as genetically engineered cells. Also provided is a liquid basal media and frozen supplements that can be used to produce serum-free media. The provided embodiments include methods for producing serum-free media and methods for culturing cells, such as activating, transducing, cultivating or expanded cells, in the presence of serum-free media.
    Type: Application
    Filed: December 7, 2018
    Publication date: July 8, 2021
    Applicant: Juno Therapeutics, Inc.
    Inventors: Pascal BEAUCHESNE, Kien KHUU-DUONG, Ivie AIFUWA, Calvin CHAN
  • Publication number: 20200384025
    Abstract: The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells and/or CD8+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for pooling enriched CD4+ and CD8+ cells, such as at a 1:1 ratio, and then incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells through transduction or transfection, and/or cultivating the cells under conditions that promote proliferation and/or expansion. In some aspects, the provided methods are an efficient, reliable means to produce genetically engineered T cells with a high degree of success.
    Type: Application
    Filed: December 7, 2018
    Publication date: December 10, 2020
    Applicant: Juno Therapeutics, Inc.
    Inventors: Mirna MUJACIC, Ayu RAHARDJO, Pascal BEAUCHESNE, Kien KHUU-DUONG, Ivie AIFUWA, Calvin CHAN